Axio was founded in 2008 by Leo Mavely, a bioengineer to develop novel biopolymer platform based products for wound care.
Axio has the distinction to be the first company from India to design, develop and commercialize an Emergency Haemostat for Trauma care.
Controlling life-threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat® is its flagship product developed to reduce the mortality due to traumatic bleeding. Axio is a ISO 13485 certified company with an experienced team focused on bringing high-impact medical products to market.
Specialties
Prehospital Wound care, Wound management, Biomaterials, Medical Devices
Axio has the distinction to be the first company from India to design, develop and commercialize an Emergency Haemostat for Trauma care.
Controlling life-threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat® is its flagship product developed to reduce the mortality due to traumatic bleeding. Axio is a ISO 13485 certified company with an experienced team focused on bringing high-impact medical products to market.
Specialties
Prehospital Wound care, Wound management, Biomaterials, Medical Devices
Location: India, Karnataka, Bengaluru
Employees: 51-200
Phone: +91 88607 86067
Total raised: $18.6M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Chiratae V... | chiratae.c... |
| 10.04.2024 | Madison In... | madison-in... |
| - | Accel Part... | accel.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 27.07.2021 | - | $6M | - |
| 09.01.2020 | Series B | $5.2M | - |
| 26.01.2018 | - | $7.4M | - |
Mentions in press and media 13
| Date | Title | Description |
| 28.07.2021 | Axio Biosolutions raises $6 million from TrueScale, others | ETtechLeo Mavely, founder and chief executive at Axio Biosolutions. (Photo: company website) Mumbai: Axio Biosolutions, a medical technology company backed by Accel and Chiratae Ventures, has raised $6 million in a Series B round led by Tru... |
| 27.07.2021 | Medtech Startup Axio Biosolutions Raises $6 Mn From TrueScale Capital, Existing Investors | Axio Biosolutions, a Boston and Bengaluru-based medical device company has raised $6 Mn in Series B2 led by TrueScale Capital. Existing investors Omidyar Network India, University of California – Ratan Tata Fund, and Accel also participated... |
| 27.07.2021 | Axio Biosolutions raises $6 million in funding led by Truescale Capital | ETtechIllustration: Rahul Awasthi Medical technology company Axio Biosolutions on Tuesday said it has raised $6 million (about Rs 45 crore) in a funding round led by Truescale Capital. Existing investors Omidyar Network India, University of... |
| 27.07.2021 | Axio Biosolutions raises $6 million in Series B2 round led by TrueScale Capital | In total, Axio has raised over $20 million till date Med-tech company Axio Biosolutions has raised $6 million in a Series B2 equity raise led by TrueScale Capital. Existing investors such as Omidyar Network India, University of California–R... |
| 27.07.2021 | Ratan Tata’s fund-backed Axio Biosolutions raises $6 million to strengthen its position in India | The round was led by TrueScale, with participation from Omidyar India, Accel and others. TrueScale’s Sameer Nath will be joining the company’s Board of Directors with this round. Axio has marked its presence in over 40 countries across the ... |
| 09.01.2020 | [Funding alert] Medtech firm Axio Biosolutions raises Rs 36 Cr led by Omidyar Network India | Axio Biosolutions, the first Indian company to get USFDA (US-Food and Drug Administration) clearance for a wound care product, on Thursday announced it has raised Rs 36 crore ($5.2 million) in Series B-1 round of funding led by Omidyar Netw... |
| 09.01.2020 | Axio Biosolutions raises Rs 36 cr in Series B-1 round led by Omidyar Network India | Axio Biosolutions, has raised Rs 36 crores ($5.2 million) in Series B-1 round of funding led by Omidyar Network India, along with participation from existing investors Accel, University of California and Ratan Tata’s UC-RNT Fund, Chiratae V... |
| 09.01.2020 | Axio Biosolutions snags $5m funding led by Omidyar Network India | Premium Medtech start-up Axio Biosolutions on Thursday said it has raised Rs36 crores ($5.2 million) in a Series B-1 round of funding, led by Omidyar Network India, along with participation from existing investors Accel, University of Calif... |
| 09.01.2020 | Omidyar leads $5.2 mn extended Series B round in Ratan Tata-backed Axio Biosolutions | Binu Paul 9 Jan, 2020 Bengaluru-based wound care products maker Axio Biosolutions has raised $5.2 million in a Series B-1 round of funding led by Omidyar Network India to fuel its global expansion plans. Returning investors such as UC-RNT F... |
| 26.01.2018 | India: Axio Biosolutions raises $7.4m led by Ratan Tata’s RNT Capital | Premium Medical devices firm Axio Biosolutions, has raised $7.4 million in a Series B funding round led by Ratan Tata’s RNT Capital. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in C... |
Show more